Home › Niet-kleincellige longkanker › Illinois › Arlington Heights
Niet-kleincellige longkanker klinische studies in Arlington Heights, IL
12 studies voor Niet-kleincellige longkanker zoeken deelnemers op locaties in en rond Arlington Heights (binnen ongeveer 30 mijl). Open een studie om te zien wie er kan deelnemen en hoe je contact opneemt met het studieteam.
Officiële studietekst (Engels)
Rekruteren voor een studie? Laat deze bovenaan deze pagina verschijnen — $99 voor 30 dagen →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
RekruterenFase 3
- Advocate Good Shepherd Hospital, Barrington · 9 mijl verwijderd
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
RekruterenFase 3
- Illinois Cancer Specialists, Arlington Heights
A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)
RekruterenFase 3
- Illinois Cancer Specialists, Arlington Heights
Prospective External Control Cohort In Patients With Newly Diagnosed Advanced or Metastatic EGFR Mutant Non-Small Cell Lung Cancer
RekruterenObservatieonderzoek
- Northwest Oncology & Hematology, Elk Grove Village · 6 mijl verwijderd
An External Control Arm Study in Non-Small Cell Lung Cancer
RekruterenObservatieonderzoek
- Northwest Oncology and Hematology, Rolling Meadows · 2 mijl verwijderd
- Northwest Oncology and Hematology, Elk Grove · 6 mijl verwijderd
- Northwest Oncology and Hematology, Hoffman Estates · 6 mijl verwijderd
- en nog 1
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
RekruterenFase 2/3
- Local Institution - 007-883-A, Arlington Heights
Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations
RekruterenFase 3
- Illinois Cancer Specialists, Arlington Heights
LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC
RekruterenFase 3
- Northwest Oncology & Hematology, Barrington · 9 mijl verwijderd
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
RekruterenFase 2
- Advocate Good Shepherd Hospital, Barrington · 9 mijl verwijderd
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
RekruterenFase 2
- Advocate Good Shepherd Hospital, Barrington · 9 mijl verwijderd
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
RekruterenFase 2/3
- Advocate Good Shepherd Hospital, Barrington · 9 mijl verwijderd
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
RekruterenObservatieonderzoek
- Advocate Good Shepherd Hospital, Barrington · 9 mijl verwijderd
Niet-kleincellige longkanker studies in andere steden
- Houston, TX145 studies
- New York City, NY121 studies
- Arlington, VA104 studies
- Nashville, TN97 studies
- Boston, MA90 studies
- Los Angeles, CA87 studies
- St. Louis, MO73 studies
- Chicago, IL61 studies
- Baltimore, MD60 studies
- San Antonio, TX59 studies
- Columbus, OH57 studies
- Washington, DC55 studies
Andere studies in Arlington Heights
- Colorectale kanker12 studies
- Longkanker9 studies
- Borstkanker7 studies
- Hartfalen7 studies
- Metastatische kanker6 studies
- Colitis ulcerosa6 studies
- Dikkedarmkanker6 studies
- Eierstokkanker5 studies
- Obesitas5 studies
- Overgewicht5 studies
- Prostaatkanker3 studies
- Huidaandoeningen3 studies
Van ClinicalTrials.gov, gegevens opgehaald op 6 okt. 2026. Elke studie stelt eigen deelnamecriteria vast; het studieteam bepaalt wie er kan deelnemen.